These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 35916335)
1. Antitumour effects of a solid lipid nanoparticle loaded with gemcitabine and oxaliplatin on the viability, apoptosis, autophagy, and Hsp90 of ovarian cancer cells. Al-Mutairi AA; Alkhatib MH J Microencapsul; 2022 Aug; 39(5):467-480. PubMed ID: 35916335 [TBL] [Abstract][Full Text] [Related]
2. Silencing of IGHG1 reverses the resistance of pancreatic cancer to multidrug chemotherapy by modulating autophagy. Tian Y; Han W; Fu L; Lv K; Zhou X Environ Toxicol; 2023 Aug; 38(8):1835-1845. PubMed ID: 37186415 [TBL] [Abstract][Full Text] [Related]
3. Thermosensitive liposomes for the delivery of gemcitabine and oxaliplatin to tumors. May JP; Ernsting MJ; Undzys E; Li SD Mol Pharm; 2013 Dec; 10(12):4499-508. PubMed ID: 24152292 [TBL] [Abstract][Full Text] [Related]
4. Silver nanoparticles enhance the apoptotic potential of gemcitabine in human ovarian cancer cells: combination therapy for effective cancer treatment. Yuan YG; Peng QL; Gurunathan S Int J Nanomedicine; 2017; 12():6487-6502. PubMed ID: 28919750 [TBL] [Abstract][Full Text] [Related]
5. Gemcitabine-loaded RGD modified liposome for ovarian cancer: preparation, characterization and pharmacodynamic studies. Tang Z; Feng W; Yang Y; Wang Q Drug Des Devel Ther; 2019; 13():3281-3290. PubMed ID: 31571830 [TBL] [Abstract][Full Text] [Related]
6. Codelivery of Gemcitabine and MUC1 Inhibitor Using PEG-PCL Nanoparticles for Breast Cancer Therapy. Behl A; Sarwalia P; Kumar S; Behera C; Mintoo MJ; Datta TK; Gupta PN; Chhillar AK Mol Pharm; 2022 Jul; 19(7):2429-2440. PubMed ID: 35639628 [TBL] [Abstract][Full Text] [Related]
7. Activation of a c-Jun N-terminal kinase-mediated autophagy pathway attenuates the anticancer activity of gemcitabine in human bladder cancer cells. Huang XL; Zhang H; Yang XY; Dong XY; Xie XY; Yin HB; Gou X; Lin Y; He WY Anticancer Drugs; 2017 Jul; 28(6):596-602. PubMed ID: 28430744 [TBL] [Abstract][Full Text] [Related]
8. DNA methyltransferase 3a modulates chemosensitivity to gemcitabine and oxaliplatin via CHK1 and AKT in p53‑deficient pancreatic cancer cells. Jing W; Song N; Liu Y; Qu X; Hou K; Yang X; Che X Mol Med Rep; 2018 Jan; 17(1):117-124. PubMed ID: 29115606 [TBL] [Abstract][Full Text] [Related]
9. Polymer Coated Iron Nanoparticles: Radiolabeling & In vitro Studies. Yilmaz S; Ichedef C; Karatay KB; Teksöz S Curr Radiopharm; 2021; 14(1):37-45. PubMed ID: 32351192 [TBL] [Abstract][Full Text] [Related]
10. Gemcitabine and oxaliplatin in patients with pancreatic adenocarcinoma: clinical and pharmacokinetic data. Airoldi M; Cattel L; Passera R; Pedani F; Milla P; Zanon C Pancreas; 2006 Jan; 32(1):44-50. PubMed ID: 16340743 [TBL] [Abstract][Full Text] [Related]
11. Gemcitabine and Antisense-microRNA Co-encapsulated PLGA-PEG Polymer Nanoparticles for Hepatocellular Carcinoma Therapy. Devulapally R; Foygel K; Sekar TV; Willmann JK; Paulmurugan R ACS Appl Mater Interfaces; 2016 Dec; 8(49):33412-33422. PubMed ID: 27960411 [TBL] [Abstract][Full Text] [Related]
12. Building and behavior of a pH-stimuli responsive chitosan nanoparticles loaded with folic acid conjugated gemcitabine silver colloids in MDA-MB-453 metastatic breast cancer cell line and pharmacokinetics in rats. Karuppaiah A; Babu D; Selvaraj D; Natrajan T; Rajan R; Gautam M; Ranganathan H; Siram K; Nesamony J; Sankar V Eur J Pharm Sci; 2021 Oct; 165():105938. PubMed ID: 34256103 [TBL] [Abstract][Full Text] [Related]
13. Gemcitabine and oxaliplatin in patients with metastatic breast cancer resistant to or pretreated with both anthracyclines and taxanes: clinical and pharmacokinetic data. Airoldi M; Cattel L; Passera R; Pedani F; Delprino L; Micari C Am J Clin Oncol; 2006 Oct; 29(5):490-4. PubMed ID: 17023785 [TBL] [Abstract][Full Text] [Related]
14. Cytotoxic effects of gemcitabine-loaded solid lipid nanoparticles in pancreatic cancer cells. Affram KO; Smith T; Ofori E; Krishnan S; Underwood P; Trevino JG; Agyare E J Drug Deliv Sci Technol; 2020 Feb; 55():. PubMed ID: 31903101 [TBL] [Abstract][Full Text] [Related]
15. Development and evaluation of folate functionalized albumin nanoparticles for targeted delivery of gemcitabine. Dubey RD; Alam N; Saneja A; Khare V; Kumar A; Vaidh S; Mahajan G; Sharma PR; Singh SK; Mondhe DM; Gupta PN Int J Pharm; 2015 Aug; 492(1-2):80-91. PubMed ID: 26165611 [TBL] [Abstract][Full Text] [Related]
16. Anti-tumor efficacy of folate modified PLGA-based nanoparticles for the co-delivery of drugs in ovarian cancer. Li S; Li X; Ding J; Han L; Guo X Drug Des Devel Ther; 2019; 13():1271-1280. PubMed ID: 31114163 [No Abstract] [Full Text] [Related]
17. Inducing enhanced immunogenic cell death with nanocarrier-based drug delivery systems for pancreatic cancer therapy. Zhao X; Yang K; Zhao R; Ji T; Wang X; Yang X; Zhang Y; Cheng K; Liu S; Hao J; Ren H; Leong KW; Nie G Biomaterials; 2016 Sep; 102():187-97. PubMed ID: 27343466 [TBL] [Abstract][Full Text] [Related]
18. Novel hyaluronic acid oligosaccharide-loaded and CD44v6-targeting oxaliplatin nanoparticles for the treatment of colorectal cancer. Du W; Yang X; He S; Wang J; Guo Y; Kou B; Jiang Y; Bian P; Li B; Yin L Drug Deliv; 2021 Dec; 28(1):920-929. PubMed ID: 33974471 [TBL] [Abstract][Full Text] [Related]
19. Precise engineering of hybrid molecules-loaded macromolecular nanoparticles shows Liu D; Zhang W; Liu X; Qiu R Drug Deliv; 2021 Dec; 28(1):776-786. PubMed ID: 33866910 [TBL] [Abstract][Full Text] [Related]
20. Improved anti-colorectal carcinomatosis effect of tannic acid co-loaded with oxaliplatin in nanoparticles encapsulated in thermosensitive hydrogel. Ren Y; Li X; Han B; Zhao N; Mu M; Wang C; Du Y; Wang Y; Tong A; Liu Y; Zhou L; You C; Guo G Eur J Pharm Sci; 2019 Feb; 128():279-289. PubMed ID: 30553061 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]